Clinical Trials
63
Active:2
Completed:38
Trial Phases
4 Phases
Phase 1:7
Phase 2:20
Phase 3:20
+1 more phases
Drug Approvals
10
NMPA:10
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (59 trials with phase data)• Click on a phase to view related trials
Phase 2
20 (33.9%)Phase 3
20 (33.9%)Not Applicable
10 (16.9%)Phase 1
7 (11.9%)phase_1_2
2 (3.4%)A Randomized Placebo-controlled Multicenter Trial to Evaluate the Efficacy and Safety of JTR-161, Allogeneic Human Dental Pulp Stem Cell, in Patients With Acute Ischemic stRoke (J-REPAIR)
Phase 1
Completed
- Conditions
- Acute Ischemic Stroke
- First Posted Date
- 2020-10-29
- Last Posted Date
- 2022-06-30
- Lead Sponsor
- Teijin Pharma Limited
- Target Recruit Count
- 79
- Registration Number
- NCT04608838
- Locations
- 🇯🇵
Nippon Medical School Hospital, Bunkyo-ku, Tokyo, Japan
News
No news found